MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 25, 2006; DOI: 10.1124/mol.106.027748


0026-895X/06/7006-2116-2126$20.00
Mol Pharmacol 70:2116-2126, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.027748v1
70/6/2116    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giordano, G.
Right arrow Articles by Costa, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giordano, G.
Right arrow Articles by Costa, L. G.

Neurotoxicity of Domoic Acid in Cerebellar Granule Neurons in a Genetic Model of Glutathione Deficiency

G. Giordano, C. C. White, L. A. McConnachie, C. Fernandez, T. J. Kavanagh, and L. G. Costa

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington (G.G., C.C.W., L.A.M., C.F., T.J.K., L.G.C.); and Department of Human Anatomy, Pharmacology, and Forensic Medicine, University of Parma Medical School, Parma, Italy (L.G.C.)

This study investigated the role of cellular antioxidant defense mechanisms in modulating the neurotoxicity of domoic acid (DomA), by using cerebellar granule neurons (CGNs) from mice lacking the modifier subunit of glutamate-cysteine ligase (Gclm). Glutamate-cysteine ligase (Glc) catalyzes the first and rate-limiting step in glutathione (GSH) biosynthesis. CGNs from Gclm (-/-) mice have very low levels of GSH and are 10-fold more sensitive to DomA-induced toxicity than CGNs from Gclm (+/+) mice. GSH ethyl ester decreased, whereas the Gcl inhibitor buthionine sulfoximine increased DomA toxicity. Antagonists of {alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors and of N-methyl-D-aspartate (NMDA) receptors blocked DomA toxicity, and NMDA receptors were activated by DomA-induced L-glutamate release. The differential susceptibility of CGNs to DomA toxicity was not due to a differential expression of ionotropic glutamate receptors, as evidenced by similar calcium responses and L-glutamate release in the two genotypes. A calcium chelator and several antioxidants antagonized DomA-induced toxicity. DomA caused a rapid decrease in cellular GSH, which preceded toxicity, and the decrease was primarily due to DomA-induced GSH efflux. DomA also caused an increase in oxidative stress as indicated by increases in reactive oxygen species and lipid peroxidation, which was subsequent to GSH efflux. Astrocytes from both genotypes were resistant to DomA toxicity and presented a diminished calcium response to DomA and a lack of DomA-induced L-glutamate release. Because polymorphisms in the GCLM gene in humans are associated with low GSH levels, such individuals, as well as others with genetic conditions or environmental exposures that lead to GSH deficiency, may be more susceptible to DomA-induced neurotoxicity.


Received June 8, 2006; accepted September 25, 2006

Address correspondence to: Dr. Lucio G. Costa, Department of Environmental and Occupational Health Sciences, University of Washington, 4225 Roosevelt Way NE, Suite 100, Seattle, WA 98105. E-mail: lgcosta{at}u.washington.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. L. VanDeMark, M. Guizzetti, G. Giordano, and L. G. Costa
The Activation of M1 Muscarinic Receptor Signaling Induces Neuronal Differentiation in Pyramidal Hippocampal Neurons
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 532 - 542.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Watabe, K. Aoyama, and T. Nakaki
A Dominant Role of GTRAP3-18 in Neuronal Glutathione Synthesis
J. Neurosci., September 17, 2008; 28(38): 9404 - 9413.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. Giordano, C. C. White, I. Mohar, T. J. Kavanagh, and L. G. Costa
Glutathione Levels Modulate Domoic Acid Induced Apoptosis in Mouse Cerebellar Granule Cells
Toxicol. Sci., December 1, 2007; 100(2): 433 - 444.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics